Belite Bio Inc - ADR

NASDAQ:BLTE

55.32

-0.08 (-0.14%)

7:10:10 PM EDT: $55.38 +0.06 (+0.11%)

Belite Bio Inc - ADR Stock, NASDAQ:BLTE

12750 High Bluff Drive, Suite 475, San Diego, California 92130

United States of America

Phone: +1.858.246.6240

Number of Employees: 20

http://www.belitebio.com

Description

Belite Bio, Inc. is a biopharmaceutical company engaged in the research and development of drugs. Its focus is on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.